跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23 条关于
“ASC50”
全部
23
临床试验
14
药物
2
机构
0
资讯
7
去年
FDA Clears Ascletis' IND for ASC50, a Novel Oral IL-17 Inhibitor for Psoriasis Treatment
去年
Ascletis' Oral GLP-1RA ASC30 Shows Promising Results in Obesity Trials
2年前
Ascletis' ASC30 Enters Phase I Trials as Novel Oral and Injectable Obesity Treatment
去年
Ascletis Completes Enrollment in Phase III Acne Trial of Oral FASN Inhibitor Denifanstat
去年
Ascletis Completes Enrollment in Phase III Trial of Denifanstat for Acne
去年
Ascletis Completes Enrollment in Phase III Trial of Denifanstat for Moderate to Severe Acne
去年
Ascletis Completes Enrollment in Phase III Trial of Denifanstat for Acne Treatment